155 related articles for article (PubMed ID: 36100603)
1. Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.
Che H; Jatsenko T; Lannoo L; Stanley K; Dehaspe L; Vancoillie L; Brison N; Parijs I; Van Den Bogaert K; Devriendt K; Severi S; De Langhe E; Vermeire S; Verstockt B; Van Calsteren K; Vermeesch JR
NPJ Genom Med; 2022 Sep; 7(1):55. PubMed ID: 36100603
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.
Che H; Jatsenko T; Lenaerts L; Dehaspe L; Vancoillie L; Brison N; Parijs I; Van Den Bogaert K; Fischerova D; Heremans R; Landolfo C; Testa AC; Vanderstichele A; Liekens L; Pomella V; Wozniak A; Dooms C; Wauters E; Hatse S; Punie K; Neven P; Wildiers H; Tejpar S; Lambrechts D; Coosemans A; Timmerman D; Vandenberghe P; Amant F; Vermeesch JR
Clin Chem; 2022 Sep; 68(9):1164-1176. PubMed ID: 35769009
[TBL] [Abstract][Full Text] [Related]
3. Maternal, neonatal, pregnancy outcome characteristics of pregnant women with high plasma cell-free DNA concentration in non-invasive prenatal screening: a retrospective analysis.
Xing L; Bai T; Liu S; Liu J; Jing X; Deng C; Xia T; Liu Y; Cheng J; Wei X; Luo Y; Zhou Q; Zhu Q; Liu H
Front Pediatr; 2023; 11():1195818. PubMed ID: 37664552
[TBL] [Abstract][Full Text] [Related]
4. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
5. A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection.
He QZ; Wu XJ; He QY; Xiang JJ; Zhang CH; Lu L; Wang T; Li H
Br J Biomed Sci; 2018 Jul; 75(3):133-138. PubMed ID: 29968522
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility of genome-wide non invasive prenatal screening.
Fiorentino F; Bono S; Pizzuti F; Duca S; Polverari A; Faieta M; Baldi M; Diano L; Spinella F
Prenat Diagn; 2017 Jun; 37(6):593-601. PubMed ID: 28423190
[TBL] [Abstract][Full Text] [Related]
7. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA.
Wan N; Weinberg D; Liu TY; Niehaus K; Ariazi EA; Delubac D; Kannan A; White B; Bailey M; Bertin M; Boley N; Bowen D; Cregg J; Drake AM; Ennis R; Fransen S; Gafni E; Hansen L; Liu Y; Otte GL; Pecson J; Rice B; Sanderson GE; Sharma A; St John J; Tang C; Tzou A; Young L; Putcha G; Haque IS
BMC Cancer; 2019 Aug; 19(1):832. PubMed ID: 31443703
[TBL] [Abstract][Full Text] [Related]
8. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
9. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women.
Yao H; Gao Y; Zhao J; Zhang R; Xu H; Hu H; Luo Y; Yuan Y; Fu M; Zhang H; Jiang H; Wang W; Yang H; Wang J; Liang Z; Chen F
Sci China Life Sci; 2019 Feb; 62(2):215-224. PubMed ID: 30076564
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
[TBL] [Abstract][Full Text] [Related]
12. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
13. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
[TBL] [Abstract][Full Text] [Related]
14. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
15. Cell-free fetal DNA screening for detection of microdeletion syndromes: a cost-effectiveness analysis.
Avram CM; Shaffer BL; Sparks TN; Allen AJ; Caughey AB
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1732-1740. PubMed ID: 31327283
[TBL] [Abstract][Full Text] [Related]
16. Finding new cancer epigenetic and genetic biomarkers from cell-free DNA by combining SALP-seq and machine learning.
Liu S; Wu J; Xia Q; Liu H; Li W; Xia X; Wang J
Comput Struct Biotechnol J; 2020; 18():1891-1903. PubMed ID: 32774784
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
Oh CR; Kong SY; Im HS; Kim HJ; Kim MK; Yoon KA; Cho EH; Jang JH; Lee J; Kang J; Park SR; Ryoo BY
BMC Cancer; 2019 Apr; 19(1):292. PubMed ID: 30935424
[TBL] [Abstract][Full Text] [Related]
18. Cell-free DNA analysis in maternal blood: comparing genome-wide versus targeted approach as a first-line screening test.
de Wergifosse S; Bevilacqua E; Mezela I; El Haddad S; Gounongbe C; de Marchin J; Maggi V; Conotte S; Badr DA; Fils JF; Guizani M; Jani JC
J Matern Fetal Neonatal Med; 2021 Nov; 34(21):3552-3561. PubMed ID: 31722585
[TBL] [Abstract][Full Text] [Related]
19. Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M; Verma RK; Kumar S; Kumar V
Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
